🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Ashley Stuckey

Ashley Stuckey

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer”.

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.018

N/A

0.908DataRank · unranked

28 citations

Michael A. Bookman, Jalid Sehouli, Austin Miller, Richard T. Penson, Çağatay Taşkıran +20 more

Depression trajectories among women undergoing chemotherapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e24144

N/A

0DataRank · unranked

0 citations

Steven M. Paul, Ashley Stuckey, Christine Miaskowski, Laura B. Dunn, Johanna A. Suskin

Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis

Brain(2023)10.1093/brain/awad240

N/A

0DataRank · unranked

72 citations

Stefania Magri, Riccardo Curró, Elena Abati, Stefano Facchini, Marinella Corbetta +95 more

Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

Nature(2020)10.1038/s41586-020-2080-8

N/A

0DataRank · unranked

1181 citations

Jens Puschhof, Axel Rosendahl Huber, Arne van Hoeck, Henry M. Wood, Jason Nomburg +95 more

A randomized phase II study comparing single-agent olaparib, single-agent cediranib, and the combinations of cediranib/olaparib, olaparib/durvalumab (MEDI4736), cediranib/durvalumab (MEDI4736), and olaparib/AZD5363 (capivasertib) in women with recurrent, persistent, or metastatic endometrial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5629

N/A

0DataRank · unranked

1 citations

David Bender, Danielle Enserro, Shannon N. Westin, Debra L. Richardson, Laura L. Holman +10 more

Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.023

N/A

0DataRank · unranked

10 citations

Helen Huang, Bradley J. Monk, Yong-Beom Kim, Moon-Hong Kim, Ashley Stuckey +14 more

Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.09.014

N/A

0DataRank · unranked

3 citations

Helen Huang, Wei Deng, Wui‐Jin Koh, William H. Rodgers, William Small +17 more